Health Protection Agency: HIV in the United Kingdom. 2011, Report. 2011
Google Scholar
May M: Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies. AIDS. 2007, 21 (9): 1185-1197.
Article
PubMed
Google Scholar
Emery S: Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. J Infect Dis. 2008, 197 (8): 1133-1144.
Article
PubMed
Google Scholar
El-Sadr WM: CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006, 355 (22): 2283-2296.
Article
CAS
PubMed
Google Scholar
Opravil M: Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count >350 × 10(6)/l. AIDS. 2002, 16 (10): 1371-1381. 10.1097/00002030-200207050-00009.
Article
CAS
PubMed
Google Scholar
Phillips AN: Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count. AIDS. 2007, 21 (13): 1717-1721.
Article
PubMed
Google Scholar
Sullivan AK: Newly diagnosed HIV infections: review in UK and Ireland. BMJ. 2005, 330 (7503): 1301-1302. 10.1136/bmj.38398.590602.E0.
Article
PubMed
PubMed Central
Google Scholar
Adler A, Mounier-Jack S, Coker RJ: Late diagnosis of HIV in Europe: definitional and public health challenges. AIDS Care. 2009, 21 (3): 284-293. 10.1080/09540120802183537.
Article
CAS
PubMed
Google Scholar
Burns FM: Missed opportunities for earlier HIV diagnosis within primary and secondary healthcare settings in the UK. AIDS. 2008, 22 (1): 115-122. 10.1097/QAD.0b013e3282f1d4b6.
Article
PubMed
Google Scholar
Lanoy E: Frequency, determinants and consequences of delayed access to care for HIV infection in France. Antivir Ther. 2007, 12 (1): 89-96.
PubMed
Google Scholar
Sabin CA: Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy. AIDS. 2004, 18 (16): 2145-2151. 10.1097/00002030-200411050-00006.
Article
PubMed
Google Scholar
Stohr W: CD4 cell count and initiation of antiretroviral therapy: trends in seven UK centres, 1997-2003. HIV Med. 2007, 8 (3): 135-141. 10.1111/j.1468-1293.2007.00443.x.
Article
CAS
PubMed
Google Scholar
Castilla J: Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence. AIDS. 2002, 16 (14): 1945-1951. 10.1097/00002030-200209270-00012.
Article
PubMed
Google Scholar
Wolbers M: Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. HIV Med. 2008, 9 (6): 397-405. 10.1111/j.1468-1293.2008.00566.x.
Article
CAS
PubMed
Google Scholar
Klein D: Review of medical encounters in the 5 years before a diagnosis of HIV-1 infection: implications for early detection. J Acquir Immune Defic Syndr. 2003, 32 (2): 143-152. 10.1097/00126334-200302010-00005.
Article
PubMed
Google Scholar
Manavi K: Heterosexual men and women with HIV test positive at a later stage of infection than homo- or bisexual men. Int J STD AIDS. 2004, 15 (12): 811-814. 10.1258/0956462042563585.
Article
CAS
PubMed
Google Scholar
Krentz HB, Auld MC, Gill MJ: The high cost of medical care for patients who present late (CD4 <200 cells/microL) with HIV infection. HIV Med. 2004, 5 (2): 93-98. 10.1111/j.1468-1293.2004.00193.x.
Article
CAS
PubMed
Google Scholar
Smith RD: HIV transmission and high rates of late diagnoses among adults aged 50 years and over. AIDS. 2010, 24 (13): 2109-2115. 10.1097/QAD.0b013e32833c7b9c.
Article
PubMed
Google Scholar
Borghi V: Late presenters in an HIV surveillance system in Italy during the period 1992-2006. J Acquir Immune Defic Syndr. 2008, 49 (3): 282-286. 10.1097/QAI.0b013e318186eabc.
Article
PubMed
Google Scholar
Johnson M, Sabin C, Girardi E: Definition and epidemiology of late presentation in Europe. Antivir Ther. 2010, 15 (Suppl 1): 3-8. 10.3851/IMP1522.
Article
PubMed
Google Scholar
Gazzard BG: British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. HIV Med. 2008, 9 (8): 563-608. 10.1111/j.1468-1293.2008.00636.x.
Article
CAS
PubMed
Google Scholar
Antinori A: Late presentation of HIV infection: a consensus definition. HIV Med. 2011, 12 (1): 61-64. 10.1111/j.1468-1293.2010.00857.x.
Article
CAS
PubMed
Google Scholar
Zoufaly A: Late presentation for HIV diagnosis and care in Germany. HIV Med. 2012, 13 (3): 172-181.
Article
CAS
PubMed
Google Scholar
Dickson NP: Late presentation of HIV infection among adults in New Zealand: 2005-2012. HIV Med. 2012, 13 (3): 182-189.
PubMed
Google Scholar
National Research Ethics Service: Does my project require review by a Research Ethics Committee?. [cited 2012 09 October 2012]; Available from: http://www.nres.nhs.uk/applications/approval-requirements/ethical-review-requirements/
Helleberg M: Late presenters, repeated testing, and missed opportunities in a Danish nationwide HIV cohort. Scand J Infect Dis. 2012, 44 (4): 282-288. 10.3109/00365548.2011.626440.
Article
PubMed
Google Scholar
Begovac J: Late presentation to care for HIV infection in Croatia and the effect of interventions during the Croatian Global Fund Project. AIDS Behav. 2008, 12 (4 Suppl): S48-S53.
Article
PubMed
Google Scholar
Delpierre C: Correlates of late HIV diagnosis: implications for testing policy. Int J STD AIDS. 2007, 18 (5): 312-317. 10.1258/095646207780749709.
Article
PubMed
PubMed Central
Google Scholar
Perry N: HIV testing in acute general medicine admissions must be universally offered to reduce undiagnosed HIIV. HIV Medicine. 2010, 11 (Supp.1): 7-8.
Google Scholar
Fisher M: Late diagnosis of HIV infection: major consequences and missed opportunities. Curr Opin Infect Dis. 2008, 21 (1): 1-3. 10.1097/QCO.0b013e3282f2d8fb.
Article
PubMed
Google Scholar
Grabar S, Weiss L, Costagliola D: HIV infection in older patients in the HAART era. J Antimicrob Chemother. 2006, 57 (1): 4-7.
Article
CAS
PubMed
Google Scholar
Manfredi R: HIV infection and advanced age emerging epidemiological, clinical, and management issues. Ageing Res Rev. 2004, 3 (1): 31-54. 10.1016/j.arr.2003.07.001.
Article
PubMed
Google Scholar
Girardi E, Sabin CA, Monforte AD: Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr. 2007, 46 (Suppl 1): S3-S8. 10.1097/01.qai.0000286597.57066.2b.
Article
PubMed
Google Scholar
Health Protection Agency: HIV in the United Kingdom. 2012, Report. 2012
Google Scholar
Sudarshi D: Missed opportunities for diagnosing primary HIV infection. Sex Transm Infect. 2008, 84 (1): 14-16. 10.1136/sti.2007.026963.
Article
CAS
PubMed
Google Scholar
Sabin CA: Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers. AIDS. 2006, 20 (1): 67-71. 10.1097/01.aids.0000196178.73174.24.
Article
PubMed
Google Scholar
Lucas SB, Curtis H, Johnson MA: National review of deaths among HIV-infected adults. Clin Med. 2008, 8 (3): 250-252.
Article
CAS
Google Scholar
Sobrino-Vegas P: Delayed diagnosis of HIV infection in a multicenter cohort: prevalence, risk factors, response to HAART and impact on mortality. Curr HIV Res. 2009, 7 (2): 224-230. 10.2174/157016209787581535.
Article
CAS
PubMed
Google Scholar
Smit C: Late entry to HIV care limits the impact of anti-retroviral therapy in The Netherlands. PLoS One. 2008, 3 (4): e1949-10.1371/journal.pone.0001949.
Article
PubMed
PubMed Central
Google Scholar
Delpierre C: Characteristics trends, mortality and morbidity in persons newly diagnosed HIV positive during the last decade: the profile of new HIV diagnosed people. Eur J Public Health. 2008, 18 (3): 345-347. 10.1093/eurpub/ckm117.
Article
CAS
PubMed
Google Scholar
Babiker AG: Age as a determinant of survival in HIV infection. J Clin Epidemiol. 2001, 54: 16-21. 10.1016/S0895-4356(01)00456-5.
Article
Google Scholar
Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe. Lancet. 2000, 355 (9210): 7-1131.
Centers for Disease Control and Prevention: Revised recommendations for HIV of adults, adolescents and pregnant women in health care settings. MMWR - Morbidity & Mortality Weekly Report. 2006, 50 (No. RR-14): 1-16.
Google Scholar
Palfreeman A: Testing for HIV: concise guidance. Clin Med. 2009, 9 (5): 471-476.
Article
Google Scholar
Centers for Disease Control and Prevention: HIV testing among pregnant women - United States and Canada, 1998-2001. MMWR - Morbidity & Mortality Weekly Report. 2002, 51: 1013-1016.
Google Scholar
Stanley B, Fraser J, Cox NH: Uptake of HIV screening in genitourinary medicine after change to "opt-out" consent. BMJ. 2003, 326 (7400): 1174-10.1136/bmj.326.7400.1174.
Article
PubMed
PubMed Central
Google Scholar
Marks G: Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005, 39 (4): 446-453. 10.1097/01.qai.0000151079.33935.79.
Article
PubMed
Google Scholar
Vernazza P: Les personnes séropositives ne souffrant d'aucune autre MST et suivant un traitement antirétroviral efficace ne transmettent pas le VIH par voie sexuelle. Bull Med Suisses. 2008, 89: 165-169.
Google Scholar
Castilla J: Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J Acquir Immune Defic Syndr. 2005, 40 (1): 96-101. 10.1097/01.qai.0000157389.78374.45.
Article
PubMed
Google Scholar